| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.82B | 2.25B | 2.03B | 1.85B | 1.53B | 1.32B |
| Gross Profit | 32.95M | 1.13B | 1.01B | 877.90M | 724.30M | 613.60M |
| EBITDA | 450.10M | 537.30M | 475.50M | 410.60M | 373.40M | 353.30M |
| Net Income | 266.90M | 296.40M | 268.80M | 234.50M | 244.40M | 203.40M |
Balance Sheet | ||||||
| Total Assets | 3.34B | 3.26B | 3.00B | 2.79B | 2.20B | 1.88B |
| Cash, Cash Equivalents and Short-Term Investments | 222.90M | 313.20M | 142.70M | 169.50M | 157.40M | 134.10M |
| Total Debt | 863.50M | 849.00M | 795.90M | 766.20M | 432.20M | 390.30M |
| Total Liabilities | 1.35B | 1.36B | 1.26B | 1.19B | 792.80M | 709.60M |
| Stockholders Equity | 1.99B | 1.90B | 1.74B | 1.60B | 1.40B | 1.17B |
Cash Flow | ||||||
| Free Cash Flow | 289.80M | 433.00M | 333.40M | 195.30M | 189.40M | 226.20M |
| Operating Cash Flow | 329.30M | 492.40M | 385.00M | 241.20M | 229.40M | 268.40M |
| Investing Cash Flow | -252.90M | -163.90M | -286.30M | -369.60M | -134.90M | -65.00M |
| Financing Cash Flow | -172.80M | -155.10M | -119.70M | 138.50M | -73.70M | -173.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £14.69B | 17.44 | 18.61% | 0.67% | 11.74% | 20.98% | |
74 Outperform | £2.65B | 8.02 | 11.47% | 3.58% | -2.44% | -6.43% | |
74 Outperform | £6.31B | 20.02 | 24.91% | 1.29% | -0.32% | -3.96% | |
73 Outperform | £8.35B | 38.47 | 14.17% | 1.13% | 11.82% | 42.93% | |
65 Neutral | £5.74B | 21.21 | 31.07% | 3.44% | 1.14% | 17.74% | |
64 Neutral | £7.22B | 15.58 | 13.46% | 1.93% | -6.93% | 18.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |